Bridgepoint Development Capital Acquires Phlexglobal

July 15, 2014

Bridgepoint Development Capital (BDC), the growth private equity arm of Bridgepoint, has acquired Phlexglobal, a UK-based provider of Trial Master File (TMF) and electronic TMF (eTMF) solutions and services. BDC plans to support Phlexglobal's technology development and international expansion to grow its client base across pharma, biotech and CRO markets.

Buyers
Bridgepoint Development Capital (BDC)
Targets
Phlexglobal
Sellers
Inflexion (previous investor)
Location
England, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.